Modification of sample size in group sequential clinical trials

Biometrics

Volumn 55, Issue 3, 1999, Pages 853-857

  Cui, Lu ^a   Hung, H M James ^a   Wang, Sue Jane ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Interim analysis; Power; Sample size; Type I error

Indexed keywords

INTERIM ANALYSIS; OBSERVED SAMPLES; POWER; SAMPLE PATH; SAMPLE SIZES; SEQUENTIAL CLINICAL TRIALS; SEQUENTIAL TESTS; SIMULATION STUDIES; TEST PROCEDURES; TYPE-I ERROR;

ERRORS;

ARTICLE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PROBABILITY; SAMPLE; SEQUENTIAL ANALYSIS; SIMULATION;

EID: 0032886394     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0006-341X.1999.00853.x     Document Type: Article

References (13)

1. Gould, A. L. (1992). Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. Statistics in Medicine 11, 55-66.
2. Gould, A. L. and Shih, W. J. (1992). Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance, Communications in Statistics -Theory and Methods 21(10), 2833-2853.
3. Lan, K. K. G. and DeMets, D. L. (1983). Discrete sequential boundaries for clinical trials. Biometrika 70, 659-663.
4. Lan, K. K. G. and Trost, D. C. (1997). Estimation of parameters and sample size reestimation. Proceedings of Biopharmaceutical Section, American Statistical Association.
5. Lan, K. K. G. and Wittes, J. (1988). The B-value: A tool for monitoring data. Biometrics 44, 579-585.
6. Lan, K. K. G., Simon, R., and Halperin, M. (1982). Stochastically curtailed tests in long-term clinical trials. Communications in Statistics C1, 207-219.
7. O'Brien, P. C. and Fleming, T. R. (1979). A multiple testing procedure for clinical trials. Biometrics 35, 549-556.
8. Pocock, S. J. (1977). Group sequential methods in the design and analysis of clinical trials. Biometrika 64, 191-199.
9. Pocock, S. J. (1982). Interim analyses for randomized clinical trials: The group sequential approach. Biometrics 38, 153-162.
10. Proschan, M. A. and Hunsberger, S. A. (1995). Designed extension of studies based on conditional power. Biometrics 51, 1315-1324.
11. Shih, W. J. (1992). Sample size reestimation in clinical trials. In Biopharmaceutical Sequential Statistical Applications, K. Peace (ed), 285-301. New York: Marcel Dekker.
12. Shih, W. J. (1993). Sample size reestimation for triple blind clinical trials. Drug Information Journal 27, 761-764.
13. Wittes, J. and Brittain, E. (1990). The role of internal pilot studies in increasing the efficiency of clinical trials. Statistics in Medicine 9, 65-72.